{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:00:47Z","timestamp":1776308447227,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Liaoning Provincial Natural Science Foundation of China","award":["2022-MS-202"],"award-info":[{"award-number":["2022-MS-202"]}]},{"name":"Liaoning Provincial Natural Science Foundation of China","award":["2022-MS-202"],"award-info":[{"award-number":["2022-MS-202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07592-2","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T13:00:21Z","timestamp":1745240421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of misoprostol versus oxytocin for labor induction in women with prelabor rupture of membranes: a meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Anluzi","family":"Che","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6730-9198","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"1","key":"7592_CR1","first-page":"e1","volume":"131","author":"Committee on Practice B-O","year":"2018","unstructured":"Committee on Practice B-O. ACOG practice bulletin 188: prelabor rupture of membranes. Obstet Gynecol. 2018;131(1):e1\u201314.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"7592_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1515\/jpm-2013-0078","volume":"41","author":"AQ Ismail","year":"2013","unstructured":"Ismail AQ, Lahiri S. Management of prelabour rupture of membranes (PROM) at term. J Perinat Med. 2013;41(6):647\u20139.","journal-title":"J Perinat Med"},{"issue":"2","key":"7592_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0095-5108(18)30528-1","volume":"18","author":"JS Gerdes","year":"1991","unstructured":"Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol. 1991;18(2):361\u201381.","journal-title":"Clin Perinatol"},{"issue":"3","key":"7592_CR4","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/AOG.0000000000003700","volume":"135","author":"Prelabor Rupture of Membranes","year":"2020","unstructured":"Prelabor Rupture of Membranes. ACOG practice bulletin, number 217. Obstet Gynecol. 2020;135(3):e80\u201397.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"7592_CR5","doi-asserted-by":"publisher","first-page":"xiii","DOI":"10.1016\/j.ogc.2020.09.002","volume":"47","author":"E Chien","year":"2020","unstructured":"Chien E, Mercer BM. Preterm premature rupture of the membranes in the Twenty-First century. Obstet Gynecol Clin North Am. 2020;47(4):xiii\u2013xiv.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"7592_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.semperi.2015.07.015","volume":"39","author":"RE Packard","year":"2015","unstructured":"Packard RE, Mackeen AD. Labor induction in the patient with preterm premature rupture of membranes. Semin Perinatol. 2015;39(6):495\u2013500.","journal-title":"Semin Perinatol"},{"issue":"16","key":"7592_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1056\/NEJM199604183341609","volume":"334","author":"P Duff","year":"1996","unstructured":"Duff P. Premature rupture of the membranes at term. N Engl J Med. 1996;334(16):1053\u20134.","journal-title":"N Engl J Med"},{"issue":"10","key":"7592_CR8","first-page":"CD000941","volume":"2010","author":"GJ Hofmeyr","year":"2010","unstructured":"Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal Misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010;2010(10):CD000941.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"7592_CR9","first-page":"637","volume":"95","author":"E Hughes","year":"2000","unstructured":"Hughes E. Cervical ripening and labor induction with a controlled-release Dinoprostone vaginal insert. Obstet Gynecol. 2000;95(4):637\u20138.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7592_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijgo.2009.03.014","volume":"106","author":"MB Nagpal","year":"2009","unstructured":"Nagpal MB, Raghunandan C, Saili A. Oral Misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. Int J Gynaecol Obstet. 2009;106(1):23\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"7592_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2217\/WHE.13.49","volume":"10","author":"ML Stephenson","year":"2014","unstructured":"Stephenson ML, Hawkins JS, Powers BL, Wing DA. Misoprostol vaginal insert for induction of labor: a delivery system with accurate dosing and rapid discontinuation. Womens Health (Lond). 2014;10(1):29\u201336.","journal-title":"Womens Health (Lond)"},{"issue":"3","key":"7592_CR12","first-page":"234","volume":"10","author":"BA Ekele","year":"2007","unstructured":"Ekele BA, Nnadi DC, Gana MA, Shehu CE, Ahmed Y, Nwobodo EI. Misoprostol use for cervical ripening and induction of labour in a Nigerian teaching hospital. Niger J Clin Pract. 2007;10(3):234\u20137.","journal-title":"Niger J Clin Pract"},{"issue":"9","key":"7592_CR13","first-page":"OC31","volume":"8","author":"M Madaan","year":"2014","unstructured":"Madaan M, Agrawal S, Puri M, Nigam A, Kaur H, Trivedi SS. Is low dose vaginal Misoprostol better than Dinoprostone gel for induction of labor: a randomized controlled trial. J Clin Diagn Res. 2014;8(9):OC31\u201334.","journal-title":"J Clin Diagn Res"},{"issue":"Suppl 2","key":"7592_CR14","first-page":"S160","volume":"99","author":"OS Tang","year":"2007","unstructured":"Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(Suppl 2):S160\u2013167.","journal-title":"Int J Gynaecol Obstet"},{"key":"7592_CR15","doi-asserted-by":"publisher","first-page":"e2744","DOI":"10.1590\/1518-8345.0765.2744","volume":"24","author":"P Hidalgo-Lopezosa","year":"2016","unstructured":"Hidalgo-Lopezosa P, Hidalgo-Maestre M, Rodriguez-Borrego MA. Labor stimulation with Oxytocin: effects on obstetrical and neonatal outcomes. Rev Lat Am Enfermagem. 2016;24:e2744.","journal-title":"Rev Lat Am Enfermagem"},{"issue":"6","key":"7592_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0029-7844(97)00113-0","volume":"89","author":"L Sanchez-Ramos","year":"1997","unstructured":"Sanchez-Ramos L, Chen AH, Kaunitz AM, Gaudier FL, Delke I. Labor induction with intravaginal Misoprostol in term premature rupture of membranes: a randomized study. Obstet Gynecol. 1997;89(6):909\u201312.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7592_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0002-9378(98)70256-X","volume":"179","author":"DA Wing","year":"1998","unstructured":"Wing DA, Paul RH. Induction of labor with Misoprostol for premature rupture of membranes beyond thirty-six weeks\u2019 gestation. Am J Obstet Gynecol. 1998;179(1):94\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"7592_CR18","first-page":"994","volume":"94","author":"KD Butt","year":"1999","unstructured":"Butt KD, Bennett KA, Crane JM, Hutchens D, Young DC. Randomized comparison of oral Misoprostol and Oxytocin for labor induction in term prelabor membrane rupture. Obstet Gynecol. 1999;94(6):994\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"7592_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1471-0528.2000.tb11693.x","volume":"107","author":"SW Ngai","year":"2000","unstructured":"Ngai SW, Chan YM, Lam SW, Lao TT. Labour characteristics and uterine activity: Misoprostol compared with Oxytocin in women at term with prelabour rupture of the membranes. BJOG. 2000;107(2):222\u20137.","journal-title":"BJOG"},{"issue":"3","key":"7592_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1067\/S0002-9378(03)00768-3","volume":"189","author":"JM Crane","year":"2003","unstructured":"Crane JM, Delaney T, Hutchens D. Oral Misoprostol for premature rupture of membranes at term. Am J Obstet Gynecol. 2003;189(3):720\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7592_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1067\/S0002-9378(03)00845-7","volume":"189","author":"E Mozurkewich","year":"2003","unstructured":"Mozurkewich E, Horrocks J, Daley S, Von Oeyen P, Halvorson M, Johnson M, Zaretsky M, Tehranifar M, Bayer-Zwirello L, Robichaux A 3, et al. The MisoPROM study: a multicenter randomized comparison of oral Misoprostol and Oxytocin for premature rupture of membranes at term. Am J Obstet Gynecol. 2003;189(4):1026\u201330.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"7592_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.AOG.0000172425.56840.57","volume":"106","author":"MG Lin","year":"2005","unstructured":"Lin MG, Nuthalapaty FS, Carver AR, Case AS, Ramsey PS. Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis. Obstet Gynecol. 2005;106(3):593\u2013601.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"7592_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/14767050600589807","volume":"19","author":"S Zetero\u011flu","year":"2006","unstructured":"Zetero\u011flu S, Engin-Ust\u00fcn Y, Ust\u00fcn Y, G\u00fcvercin\u00e7i M, Sahin G, Kamaci M. A prospective randomized study comparing Misoprostol and Oxytocin for premature rupture of membranes at term. J Matern Fetal Neonatal Med. 2006;19(5):283\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"7592_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.59779\/jiomnepal.623","volume":"35","author":"S Maskey","year":"2013","unstructured":"Maskey S, Singh M, Rawal S. Comparison of oral Misoprostol with intravenous Oxytocin for induction of labour in premature rupture of membranes. J Inst Med Nepal (JIOMN). 2013;35(2):65\u201370.","journal-title":"J Inst Med Nepal (JIOMN)"},{"issue":"9","key":"7592_CR25","first-page":"303","volume":"91","author":"CM Mbaluka","year":"2014","unstructured":"Mbaluka CM, Kamau K, Karanja JG, Mugo N, EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM. A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL. East Afr Med J. 2014;91(9):303\u201310.","journal-title":"East Afr Med J"},{"issue":"1","key":"7592_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/1110-2098.156001","volume":"28","author":"AA Shabana","year":"2015","unstructured":"Shabana AA, El Khouly NI, El Kilani OA, Tayel SM. Comparison of oral Misoprostol and Oxytocin for labor induction in prelabor rupture of membranes at term. Menoufia Med J. 2015;28(1):239\u201344.","journal-title":"Menoufia Med J"},{"issue":"1","key":"7592_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5005\/jp-journals-10006-1375","volume":"8","author":"S Anjum","year":"2016","unstructured":"Anjum S, Sharma R. Oral Misoprostol vs intravenous Oxytocin infusion for induction of labor in prelabor rupture of membranes. J South Asian Federation Obstet Gynecol. 2016;8(1):4\u20137.","journal-title":"J South Asian Federation Obstet Gynecol"},{"issue":"2","key":"7592_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/01443615.2017.1329284","volume":"38","author":"L Pouralil","year":"2018","unstructured":"Pouralil L, Saghafi N, Eslami Hasan Abadi S, Tara F, Vatanchi AM, Motamedi E. Induction of labour in term premature rupture of membranes; Oxytocin versus Sublingual Misoprostol; a randomised clinical trial. J Obstet Gynaecol. 2018;38(2):167\u201371.","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"7592_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.21608\/ebwhj.2020.20284.1060","volume":"10","author":"NK Abdel-Aal","year":"2020","unstructured":"Abdel-Aal NK, Saad AS, Yehia W. Oxytocin versus Sublingual Misoprostol for induction of labour in term prelabour rupture of membranes: a randomized controlled trial. Evid Based Women\u2019s Health J. 2020;10(4):291\u20137.","journal-title":"Evid Based Women\u2019s Health J"},{"issue":"3","key":"7592_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.18203\/2320-1770.ijrcog20200868","volume":"9","author":"JJ Bhatu","year":"2020","unstructured":"Bhatu JJ, Chaudhari AB, Chauhan NR. Oxytocin versus Misoprostol used as an induction of labour in term in early rupture of amniotic membranes. Int J Reprod Contracept Obstet Gynecol. 2020;9(3):1023\u20139.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"1","key":"7592_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.33545\/gynae.2021.v5.i1f.837","volume":"5","author":"H Tayab","year":"2021","unstructured":"Tayab H, Agrawal S, Lal P. Comparative study of efficacy and safety of Misoprostol and Oxytocin for induction in premature rupture of membrane at term. Int J Clin Obstet Gynecol. 2021;5(1):352\u20136.","journal-title":"Int J Clin Obstet Gynecol"},{"issue":"10","key":"7592_CR32","first-page":"91","volume":"3","author":"SA Muhmed","year":"2022","unstructured":"Muhmed SA, Abdelmoaty MA. Oxytocin versus vaginal Misoprostol for induction of labour in pregnant women with term pre-labour rupture of membranes. Al-Azhar Int Med J. 2022;3(10):91\u20137.","journal-title":"Al-Azhar Int Med J"},{"key":"7592_CR33","doi-asserted-by":"crossref","unstructured":"Unthanan S, Petcharat K, Prommas S, Smanchat B, Bhamarapravatana K, Suwannarurk K. Sublingual Misoprostol versus Oxytocin to Induce Labor in Term Premature Rupture of Membranes in Pregnant Women: A Randomized Single-Blind Controlled Trial. Biomed Res Int 2022, 2022:9449036.","DOI":"10.1155\/2022\/9449036"},{"issue":"12","key":"7592_CR34","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s43032-023-01290-0","volume":"30","author":"RHM Ahmed","year":"2023","unstructured":"Ahmed RHM, Sweed MSE, El-Bishry GA, Hassan RK. Oxytocin versus oral Misoprostol for induction of labor in pregnant women with term prelabor rupture of membranes: a randomized clinical trial. Reprod Sci. 2023;30(12):3507\u201314.","journal-title":"Reprod Sci"},{"issue":"12","key":"7592_CR35","first-page":"678","volume":"15","author":"A Kumari","year":"2023","unstructured":"Kumari A, Bansal A. A comparative study of maternal & neonatal outcome and patient satisfaction with intravaginal Misoprostol versus intravenous Oxytocin in patients with premature rupture of membranes beyond 36 weeks gestation. Int J Curr Pharm Rev Res. 2023;15(12):678\u201381.","journal-title":"Int J Curr Pharm Rev Res"},{"issue":"8","key":"7592_CR36","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.ajogmf.2024.101414","volume":"6","author":"WR Bender","year":"2024","unstructured":"Bender WR, McCoy JA, Levine LD. Oxytocin vs oral Misoprostol for PROM induction in Nulliparas with unfavorable cervix: a randomized trial. Am J Obstet Gynecol MFM. 2024;6(8):101414.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"7592_CR37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"7","key":"7592_CR38","doi-asserted-by":"publisher","first-page":"e0298852","DOI":"10.1371\/journal.pone.0298852","volume":"19","author":"D Jayasundara","year":"2024","unstructured":"Jayasundara D, Jayawardane IA, Weliange SDS, Jayasingha T, Madugalle T. Impact of continuous labor companion- who is the best: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2024;19(7):e0298852.","journal-title":"PLoS ONE"},{"issue":"2","key":"7592_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ijgo.15378","volume":"166","author":"D Jayasundara","year":"2024","unstructured":"Jayasundara D, Jayawardane IA, Denuwara H, Jayasingha T. Membrane sweeping at term to promote spontaneous labor and reduce the likelihood of formal labor induction for prolonged pregnancy, in South Asia and the world: A meta-analysis. Int J Gynaecol Obstet. 2024;166(2):567\u201379.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"7592_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","journal-title":"Res Synth Methods"},{"key":"7592_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijid.2022.04.013","volume":"120","author":"K Liu","year":"2022","unstructured":"Liu K, Wang X, Song G. Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis. Int J Infect Dis. 2022;120:33\u201340.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"7592_CR42","first-page":"CD010648","volume":"2013","author":"JP Vogel","year":"2013","unstructured":"Vogel JP, West HM, Dowswell T. Titrated oral Misoprostol for augmenting labour to improve maternal and neonatal outcomes. Cochrane Database Syst Rev. 2013;2013(9):CD010648.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"7592_CR43","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1055\/s-0038-1675351","volume":"8","author":"S Pierce","year":"2018","unstructured":"Pierce S, Bakker R, Myers DA, Edwards RK. Clinical insights for cervical ripening and labor induction using prostaglandins. AJP Rep. 2018;8(4):e307\u201314.","journal-title":"AJP Rep"},{"issue":"3","key":"7592_CR44","first-page":"449","volume":"117","author":"XM Li","year":"2004","unstructured":"Li XM, Wan J, Xu CF, Zhang Y, Fang L, Shi ZJ, Li K. Misoprostol in labour induction of term pregnancy: a meta-analysis. Chin Med J (Engl). 2004;117(3):449\u201352.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"7592_CR45","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1471-0528.2009.02274.x","volume":"116","author":"R Wuntakal","year":"2009","unstructured":"Wuntakal R, Erskine K. Evaluation of postpartum blood loss after misoprostol-induced labour. BJOG. 2009;116(11):1535. author reply 1535\u20131536.","journal-title":"BJOG"},{"key":"7592_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2023.11.006","volume":"292","author":"A Ameri","year":"2024","unstructured":"Ameri A, Jafariazar Z, Annabi M, Davari M. Effect of Misoprostol versus Oxytocin on delivery outcomes after labour induction in pregnant women: A systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2024;292:75\u201388.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7592_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2393-11-84","volume":"11","author":"EL Mozurkewich","year":"2011","unstructured":"Mozurkewich EL, Chilimigras JL, Berman DR, Perni UC, Romero VC, King VJ, Keeton KL. Methods of induction of labour: a systematic review. BMC Pregnancy Childbirth. 2011;11:84.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"7592_CR48","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ajog.2004.02.045","volume":"190","author":"DA Wing","year":"2004","unstructured":"Wing DA, Fassett MJ, Guberman C, Tran S, Parrish A, Guinn D. A comparison of orally administered Misoprostol to intravenous Oxytocin for labor induction in women with favorable cervical examinations. Am J Obstet Gynecol. 2004;190(6):1689\u201396.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"7592_CR49","first-page":"CD014484","volume":"6","author":"RS Kerr","year":"2021","unstructured":"Kerr RS, Kumar N, Williams MJ, Cuthbert A, Aflaifel N, Haas DM, Weeks AD. Low-dose oral Misoprostol for induction of labour. Cochrane Database Syst Rev. 2021;6(6):CD014484.","journal-title":"Cochrane Database Syst Rev"},{"key":"7592_CR50","first-page":"889","volume":"7","author":"C Patte","year":"2015","unstructured":"Patte C, Deruelle P. A critical appraisal of the Misoprostol removable, controlled-release vaginal delivery system of labor induction. Int J Womens Health. 2015;7:889\u201399.","journal-title":"Int J Womens Health"},{"issue":"3","key":"7592_CR51","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00404-022-06867-9","volume":"308","author":"V Pergialiotis","year":"2023","unstructured":"Pergialiotis V, Panagiotopoulos M, Constantinou T, Vogiatzi Vokotopoulou L, Koumenis A, Stavros S, Voskos A, Daskalakis G. Efficacy and safety of oral and Sublingual versus vaginal Misoprostol for induction of labour: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;308(3):727\u201375.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"7592_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40001-023-01007-8","volume":"28","author":"M Rahimi","year":"2023","unstructured":"Rahimi M, Haghighi L, Baradaran HR, Azami M, Larijani SS, Kazemzadeh P, Moradi Y. Comparison of the effect of oral and vaginal Misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies. Eur J Med Res. 2023;28(1):51.","journal-title":"Eur J Med Res"},{"issue":"2","key":"7592_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1515\/JPM.2007.026","volume":"35","author":"R Levy","year":"2007","unstructured":"Levy R, Vaisbuch E, Furman B, Brown D, Volach V, Hagay ZJ. Induction of labor with oral Misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double-blind, placebo-controlled trial. J Perinat Med. 2007;35(2):126\u20139.","journal-title":"J Perinat Med"},{"issue":"9","key":"7592_CR54","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1055\/s-0036-1580608","volume":"33","author":"H Kruit","year":"2016","unstructured":"Kruit H, Tihtonen K, Raudaskoski T, Ulander VM, Aitokallio-Tallberg A, Heikinheimo O, Paavonen J, Rahkonen L. Foley catheter or oral Misoprostol for induction of labor in women with term premature rupture of membranes: A randomized multicenter trial. Am J Perinatol. 2016;33(9):866\u201372.","journal-title":"Am J Perinatol"},{"issue":"4","key":"7592_CR55","doi-asserted-by":"publisher","first-page":"100868","DOI":"10.1016\/j.ajogmf.2023.100868","volume":"5","author":"S Mokhtarpour","year":"2023","unstructured":"Mokhtarpour S, Sahhaf F, Vahedi L, Sani A. Evaluation of mechanical and nonmechanical methods of cervix ripening in women with pre-labor rupture of membranes: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023;5(4):100868.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"7592_CR56","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ajog.2017.04.038","volume":"217","author":"JMH Amorosa","year":"2017","unstructured":"Amorosa JMH, Stone J, Factor SH, Booker W, Newland M, Bianco A. A randomized trial of Foley bulb for labor induction in premature rupture of membranes in Nulliparas (FLIP). Am J Obstet Gynecol. 2017;217(3):360. e361-360 e367.","journal-title":"Am J Obstet Gynecol"},{"issue":"S 01","key":"7592_CR57","doi-asserted-by":"publisher","first-page":"e3030","DOI":"10.1055\/a-2185-4102","volume":"41","author":"HB Gomez Slagle","year":"2024","unstructured":"Gomez Slagle HB, Hoffman MK, Sciscione AC, Ma\u2019ayeh M. Combination Foley Catheter-Oxytocin versus Oxytocin alone following preterm premature rupture of membranes. Am J Perinatol. 2024;41(S 01):e3030\u20134.","journal-title":"Am J Perinatol"},{"key":"7592_CR58","doi-asserted-by":"crossref","unstructured":"Farina A, Cavoretto PI, Syngelaki A, Morano D, Adjahou S, Nicolaides KH. The 36-week preeclampsia risk by the fetal medicine foundation algorithm is associated with fetal compromise following induction of labor. Am J Obstet Gynecol 2024:S0002-9378(0024)01209\u2013\u200901202.","DOI":"10.1016\/j.ajog.2024.12.025"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07592-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:02:24Z","timestamp":1745244144000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07592-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7592"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07592-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board (IRB) of the First Hospital of China Medical University (NO. 2025034 on Jan 27, 2025). The study followed the principles of the Declaration of Helsinki. The IRB of the First Hospital of China Medical University waived the need for informed consent because this was a meta-analysis study based on published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"461"}}